Invention Grant
US07645763B2 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition
有权
8- [3-氨基 - 哌啶-1-基] - 黄嘌呤，它们的制备及其作为药物组合物的用途
![8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition](/docs/US/2010-01-12/US07645763B2/abs.jpg.600x600.jpg)
- Patent Title: 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition
- Patent Title (中): 8- [3-氨基 - 哌啶-1-基] - 黄嘌呤，它们的制备及其作为药物组合物的用途
-
Application No.: US11062518Application Date: 2005-02-22
-
Publication No.: US07645763B2Publication Date: 2010-01-12
- Inventor: Frank Himmelsbach , Elke Langkopf , Matthias Eckhardt , Mohammad Tadayyon , Leo Thomas
- Applicant: Frank Himmelsbach , Elke Langkopf , Matthias Eckhardt , Mohammad Tadayyon , Leo Thomas
- Applicant Address: DE Ingelheim
- Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
- Current Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
- Current Assignee Address: DE Ingelheim
- Agent Michael P. Morris; Mary-Ellen M. Devlin; David L. Kershner
- Priority: DE102004009039 20040223
- Main IPC: C07D473/06
- IPC: C07D473/06 ; C07D519/00 ; A61K31/522 ; A61P3/10 ; A61P3/04
![8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition](/abs-image/US/2010/01/12/US07645763B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to substituted xanthines of general formula wherein R1 and R2 are defined as in the claims, the tautomers, the stereoisomers, the mixtures thereof, and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
Public/Granted literature
- US20050187227A1 8-[3-Amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition Public/Granted day:2005-08-25
Information query
